ClinicalTrials.Veeva

Menu

Development and Needs Assessment and Efficiency of Smart Communication System for Patients With ALS (Part 2)

T

Taipei Veterans General Hospital

Status

Unknown

Conditions

Amyotrophic Lateral Sclerosis

Study type

Observational

Funder types

Other

Identifiers

NCT03806634
2018-09-001A-2

Details and patient eligibility

About

The research is aimed to asses the validity of the communication system improving the quality of life and the degree of sanctification of clinical patients and their caregiver.

Enrollment

20 estimated patients

Sex

All

Ages

20+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Escorial revised criteria (Brooks et al., 2000),The diagnosis of ALS requires:

(A) the presence of:

  • (A:1) evidence of lower motor neuron (LMN) degeneration by clinical, electrophysiological or neuropathologic examination (A:2) evidence of upper motor neuron (UMN) degeneration by clinical examination, and

  • (A:3) progressive spread of symptoms or signs within a region or to other regions, as determined by history or examination, together with: (B) the absence of (B:1) electrophysiological or pathological evidence of other disease processes that might explain the signs of LMN and/or UMN degeneration, and (B:2) neuroimaging evidence of other disease processes that might explain the observed clinical and electrophysiological signs.

    • If they were Taiwanese and used traditional Chinese(Mandarin).
    • If they were older than age 20 years.

Exclusion criteria

  • If they had been diagnosed with frontotemporal dementia, severe depression, or schizophrenia.
  • If they cannot see the communication board after correction.
  • If they cannot complete the questionnaire with researchers or family members help.

Trial contacts and locations

1

Loading...

Central trial contact

Cheng Liang Chou; Si Huei Li

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems